The effect of beta‐blocker therapy on quality of life in heart failure patients: a systematic review and meta‐analysis

D Dobre, CHM van Jaarsveld… - … and drug safety, 2007 - Wiley Online Library
Purpose To assess the impact of β‐blocker therapy on quality of life (QoL) in chronic heart
failure (CHF) patients receiving optimal standard medication. Methods Randomised …
被引用次数：73 相关文章

The effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis

D Dobre, CHM van Jaarsveld, JL Mike… - … and Drug Safety, 2007 - research.rug.nl
Purpose To assess the impact of beta-blocker therapy on quality of life (QoL) in chronic heart
failure (CHF) patients receiving optimal standard medication. Methods Randomised …

[引用][C] The effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis

D DOBRE - Pharmacoepidemiol Drug Saf, 2007 - cir.nii.ac.jp
The effect of beta-blocker therapy on quality of life in heart failure patients : a systematic
review and meta-analysis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
[PDF] psu.edu

[PDF][PDF] The effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis y

MJL deJongste - pharmacoepidemiology and drug safety, 2007 - Citeseer
Purpose To assess the impact of b-blocker therapy on quality of life (QoL) in chronic heart
failure (CHF) patients receiving optimal standard medication. Methods Randomised …

The effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis.

D Dobre, CH van Jaarsveld, HR FM… - … and Drug Safety, 2007 - europepmc.org
Purpose To assess the impact of beta-blocker therapy on quality of life (QoL) in chronic heart
failure (CHF) patients receiving optimal standard medication. Methods Randomised …

The effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis

D Dobre, CHM van Jaarsveld… - … and drug safety, 2007 - pubmed.ncbi.nlm.nih.gov
Purpose To assess the impact of beta-blocker therapy on quality of life (QoL) in chronic heart
failure (CHF) patients receiving optimal standard medication. Methods Randomised …